在疫苗有效性现场试验中,积极未标记的学习可以推断保护状态并识别相关性
Shiwei Xu1, Natasha S Kelkar2, Margaret E Ackerman1,2,3
1Quantitative Biological Sciences Program, Dartmouth College, Hanover, NH 03755, USA.
iScience
|September 19, 2024
概括
这项研究引入了积极未标记 (PU) 学习,以识别疫苗的保护相关值 (CoP). PU学习有效地发现了传统方法遗漏的关键免疫标记,帮助疫苗开发.
科学领域:
- 免疫学 免疫学 免疫学
- 机器学习 机器学习
- 疫苗学 疫苗学 疫苗学
背景情况:
- 保护相关值 (CoP) 对于疫苗开发至关重要,但由于暴露率和疗效较低,在现场试验中难以确定.
- 现有的方法很难确定病原体的COP,需要取得重大进展.
研究的目的:
- 通过免疫原性数据和感染状况,评估积极未标记 (PU) 学习方法在识别COP方面的有效性.
- 克服对高需求病原体发现COP的局限性.
主要方法:
- 使用了PU包装和两步可靠的负面技术的组合.
- 将这些方法应用于人体和动物研究中的合成和现实世界的幽默免疫反应概况.
- 将PU学习结果与传统感染状况病例控制分析进行比较.
主要成果:
- 在未标记的 (未感染的) 样本中,PU学习准确地分类了保护状态.
- 这种方法成功地确定了以前传统分析错过的COP.
- 在人类和动物模型数据集中展示了PU学习的实用性.
结论:
- 积极无标记 (PU) 学习为发现保护相关性 (CoP) 提供了一个强大的策略.
- 这种方法增强了对疫苗开发的关键免疫标记物的识别,特别是对于具有挑战性的病原体.
- 这些发现表明,PU学习可以通过发现以前未知的保护性免疫反应来改善疫苗研究.
更多相关视频
09:03Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
8.6K
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
1.9K
相关概念视频
01:51Vaccinations
44.1K
Overview
44.1K
01:31Active versus Passive Immunity
592
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Active Immunity
Active immunity refers to the resistance one develops...
592
01:30Cancer Vaccines
345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345